en

PRODUCT DETAIL

Pazopanib Accord 400 mg filmom obalené tablety

Code 5797E
MA number 44/0056/24-S
Product Form: tbl flm 30x1x400 mg (blis.PVC/PE/PVDC/Al) - jednotk.bal.
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX03 Pazopanib
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 16.04.2024
Validity: 16.04.2029
Pediatric warnings: Yes
PIL: PIL_Pazopanib Accord_03_2024.pdf  
SPC: SPC_Pazopanib Accord_03_2024.pdf  
Safety feature Yes
Data update: 22.04.2024
eu-flag.png sk-flag.png